CHICAGO--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ), a leader in branded cannabis products and operator of Sunnyside dispensaries, has announced its financial results reporting date for the full year and quarter ended December 31, 2025. The company will reveal these results on Thursday, March 5, 2026, before the market opens.
A conference call and webcast will be held to discuss the financial results and provide key highlights to investors.
Event Details
Event: Cresco Labs Fourth Quarter 2025 Earnings Conference Call
Date: Thursday, March 5, 2026
Time: 8:30 am ET
Webcast: LINK
Conference Call Registration: LINK
Dial-in: 1-833-470-1428 (US Toll Free), 1-646-844-6383 (US Local)
Access Code: 152399
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
Cresco Labs is committed to normalizing and professionalizing the cannabis industry through a consumer packaged goods (CPG) approach. It focuses on building national brands and providing a customer-oriented retail experience. The company acts as a steward for the industry on legislative and regulatory initiatives. Cresco Labs leads in cultivation, production, and branded product distribution, expanding its brand portfolio which includes Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s, and Remedi.
Operating under the Sunnyside brand, Cresco Labs emphasizes patient and consumer trust while offering education and convenience through a traditional retail experience. The company embraces community support through year-round policy efforts, outreach, and the SEED initiative, which fosters authentic engagement, economic opportunity, investment, workforce development, and responsible legislative initiatives.
For more information about Cresco Labs and its journey, visit www.crescolabs.com or follow the company on Facebook, X, or LinkedIn. Additionally, explore more about stocks and market trends on Inside Ticker.